- Home
- ELDN vs CYBN Comparison
ELDN vs CYBN Comparison
Compare ELDN & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- CYBN
- Stock Information
- Founded
- ELDN 2004
- CYBN 2019
- Country
- ELDN United States
- CYBN Canada
- Employees
- ELDN N/A
- CYBN N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- ELDN Health Care
- CYBN Health Care
- Exchange
- ELDN Nasdaq
- CYBN Nasdaq
- Market Cap
- ELDN 178.4M
- CYBN 163.6M
- IPO Year
- ELDN N/A
- CYBN N/A
- Fundamental
- Price
- ELDN $2.68
- CYBN $8.34
- Analyst Decision
- ELDN Strong Buy
- CYBN Strong Buy
- Analyst Count
- ELDN 2
- CYBN 4
- Target Price
- ELDN $12.50
- CYBN $86.00
- AVG Volume (30 Days)
- ELDN 609.3K
- CYBN 280.3K
- Earning Date
- ELDN 08-18-2025
- CYBN 08-07-2025
- Dividend Yield
- ELDN N/A
- CYBN N/A
- EPS Growth
- ELDN N/A
- CYBN N/A
- EPS
- ELDN N/A
- CYBN N/A
- Revenue
- ELDN N/A
- CYBN N/A
- Revenue This Year
- ELDN N/A
- CYBN N/A
- Revenue Next Year
- ELDN N/A
- CYBN N/A
- P/E Ratio
- ELDN N/A
- CYBN N/A
- Revenue Growth
- ELDN N/A
- CYBN N/A
- 52 Week Low
- ELDN $2.30
- CYBN $4.81
- 52 Week High
- ELDN $5.54
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- ELDN 38.39
- CYBN 54.73
- Support Level
- ELDN $2.60
- CYBN $7.11
- Resistance Level
- ELDN $2.91
- CYBN $8.19
- Average True Range (ATR)
- ELDN 0.17
- CYBN 0.55
- MACD
- ELDN -0.02
- CYBN -0.08
- Stochastic Oscillator
- ELDN 16.98
- CYBN 54.45
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.